320 related articles for article (PubMed ID: 21252521)
1. Experimental models of vasculitis and glomerulonephritis induced by antineutrophil cytoplasmic autoantibodies.
Jennette JC; Xiao H; Falk R; Gasim AMH
Contrib Nephrol; 2011; 169():211-220. PubMed ID: 21252521
[TBL] [Abstract][Full Text] [Related]
2. Complement in ANCA-associated vasculitis.
Charles Jennette J; Xiao H; Hu P
Semin Nephrol; 2013 Nov; 33(6):557-64. PubMed ID: 24161040
[TBL] [Abstract][Full Text] [Related]
3. Bone marrow-derived cells are sufficient and necessary targets to mediate glomerulonephritis and vasculitis induced by anti-myeloperoxidase antibodies.
Schreiber A; Xiao H; Falk RJ; Jennette JC
J Am Soc Nephrol; 2006 Dec; 17(12):3355-64. PubMed ID: 17108314
[TBL] [Abstract][Full Text] [Related]
4. Impact of anti-glomerular basement membrane antibodies and glomerular neutrophil activation on glomerulonephritis in experimental myeloperoxidase-antineutrophil cytoplasmic antibody vasculitis.
Kanzaki G; Nagasaka S; Higo S; Kajimoto Y; Kanemitsu T; Aoki M; Nagahama K; Natori Y; Tsuboi N; Yokoo T; Shimizu A
Nephrol Dial Transplant; 2016 Apr; 31(4):574-85. PubMed ID: 26582929
[TBL] [Abstract][Full Text] [Related]
5. Lessons from a double-transgenic neutrophil approach to induce antiproteinase 3 antibody-mediated vasculitis in mice.
Schreiber A; Eulenberg-Gustavus C; Bergmann A; Jerke U; Kettritz R
J Leukoc Biol; 2016 Dec; 100(6):1443-1452. PubMed ID: 27365530
[TBL] [Abstract][Full Text] [Related]
6. Alternative complement pathway in the pathogenesis of disease mediated by anti-neutrophil cytoplasmic autoantibodies.
Xiao H; Schreiber A; Heeringa P; Falk RJ; Jennette JC
Am J Pathol; 2007 Jan; 170(1):52-64. PubMed ID: 17200182
[TBL] [Abstract][Full Text] [Related]
7. Influence of variable domain glycosylation on anti-neutrophil cytoplasmic autoantibodies and anti-glomerular basement membrane autoantibodies.
Xu PC; Gou SJ; Yang XW; Cui Z; Jia XY; Chen M; Zhao MH
BMC Immunol; 2012 Mar; 13():10. PubMed ID: 22404873
[TBL] [Abstract][Full Text] [Related]
8. Complement system activation in ANCA vasculitis: A translational success story?
Kallenberg CG; Heeringa P
Mol Immunol; 2015 Nov; 68(1):53-6. PubMed ID: 26597208
[TBL] [Abstract][Full Text] [Related]
9. Antineutrophil cytoplasmic autoantibodies specific for myeloperoxidase cause glomerulonephritis and vasculitis in mice.
Xiao H; Heeringa P; Hu P; Liu Z; Zhao M; Aratani Y; Maeda N; Falk RJ; Jennette JC
J Clin Invest; 2002 Oct; 110(7):955-63. PubMed ID: 12370273
[TBL] [Abstract][Full Text] [Related]
10. Vasculitis and crescentic glomerulonephritis in a newly established congenic mouse strain derived from ANCA-associated vasculitis-prone SCG/Kj mice.
Hamano Y; Ito F; Suzuki O; Koura M; Matsuoka S; Kobayashi T; Sugitani Y; Wali N; Koyanagi A; Hino O; Suzuki S; Sugamata R; Yoshizawa H; Yumura W; Maruyama N; Kameoka Y; Noda Y; Hasegawa Y; Arai T; Suzuki K
Autoimmunity; 2019; 52(5-6):208-219. PubMed ID: 31476889
[TBL] [Abstract][Full Text] [Related]
11. Neutrophil Gelatinase-Associated Lipocalin Protects from ANCA-Induced GN by Inhibiting T
Schreiber A; Rousselle A; Klocke J; Bachmann S; Popovic S; Bontscho J; Schmidt-Ott KM; Siffrin V; Jerke U; Ashraf MI; Panzer U; Kettritz R
J Am Soc Nephrol; 2020 Jul; 31(7):1569-1584. PubMed ID: 32487561
[TBL] [Abstract][Full Text] [Related]
12. Pathogenesis of vascular inflammation by anti-neutrophil cytoplasmic antibodies.
Jennette JC; Xiao H; Falk RJ
J Am Soc Nephrol; 2006 May; 17(5):1235-42. PubMed ID: 16624929
[TBL] [Abstract][Full Text] [Related]
13. Pathogenesis of ANCA-associated vasculitis: new possibilities for intervention.
Kallenberg CG; Stegeman CA; Abdulahad WH; Heeringa P
Am J Kidney Dis; 2013 Dec; 62(6):1176-87. PubMed ID: 23810690
[TBL] [Abstract][Full Text] [Related]
14. Granulocyte colony stimulating factor exacerbates antineutrophil cytoplasmic antibody vasculitis.
Freeley SJ; Coughlan AM; Popat RJ; Dunn-Walters DK; Robson MG
Ann Rheum Dis; 2013 Jun; 72(6):1053-8. PubMed ID: 23087180
[TBL] [Abstract][Full Text] [Related]
15. The rise of complement in ANCA-associated vasculitis: from marginal player to target of modern therapy.
Trivioli G; Vaglio A
Clin Exp Immunol; 2020 Dec; 202(3):403-406. PubMed ID: 32946609
[TBL] [Abstract][Full Text] [Related]
16. Animal models of anti-neutrophil cytoplasmic antibody-associated vasculitis.
Coughlan AM; Freeley SJ; Robson MG
Clin Exp Immunol; 2012 Sep; 169(3):229-37. PubMed ID: 22861362
[TBL] [Abstract][Full Text] [Related]
17. Two types of myeloperoxidase-antineutrophil cytoplasmic autoantibodies with a high affinity and a low affinity in small vessel vasculitis.
Yoshida M; Sasaki M; Nakabayashi I; Akashi M; Tomiyasu T; Yoshikawa N; Kojima T; Ohno N; Yamada M
Clin Exp Rheumatol; 2009; 27(1 Suppl 52):S28-32. PubMed ID: 19646343
[TBL] [Abstract][Full Text] [Related]
18. IgG glycan hydrolysis attenuates ANCA-mediated glomerulonephritis.
van Timmeren MM; van der Veen BS; Stegeman CA; Petersen AH; Hellmark T; Collin M; Heeringa P
J Am Soc Nephrol; 2010 Jul; 21(7):1103-14. PubMed ID: 20448018
[TBL] [Abstract][Full Text] [Related]
19. Pathogenesis of ANCA-Associated Pulmonary Vasculitis.
Alba MA; Jennette JC; Falk RJ
Semin Respir Crit Care Med; 2018 Aug; 39(4):413-424. PubMed ID: 30404109
[TBL] [Abstract][Full Text] [Related]
20. Antineutrophil cytoplasmic antibodies (ANCA) and systemic vasculitis: update of assays, immunopathogenesis, controversies, and report of a novel de novo ANCA-associated vasculitis after kidney transplantation.
Schultz DR; Diego JM
Semin Arthritis Rheum; 2000 Apr; 29(5):267-85. PubMed ID: 10805352
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]